ReviewJACS Au2026
Compartmentalized Liquid Microenvironments of Pickering Emulsion Droplets for Continuous-Flow Catalysis.
Review in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transitioning catalysis from batch to continuous flow remains a key objective of sustainable chemistry, yet the effective retention of homogeneous catalysts and enzymes under flow conditions is a persistent challenge. This Perspective highlights Pickering emulsion droplet (PED)-based fixed-bed reactors as a modular strategy that enables continuous-flow catalysis by confining homogeneous catalysts and enzymes within particle-stabilized liquid microdomains that can be directly packed into column reactors. Owing to the high structural stability of droplets under flow, their strong confinement capability, and favorable liquid microenvironments that preserve catalytic activity, as well as the near-plug-flow behavior of the packed-bed, PED-based systems fundamentally differ from conventional solid-supported fixed-bed reactors and exhibit enhanced catalytic efficiency and long-term operational stability. We summarize the evolution of PED architectures from simple Pickering emulsion droplets to shell-engineered microcapsules, multicompartmentalized biomimetic microreactors, and mechanically reinforced supraparticles. Applications in enzymatic catalysis, enzyme-cofactor systems, chemoenzymatic cascades, homogeneous catalysis, and photo- and electrocatalysis are discussed. Finally, we outline future directions toward establishing a theoretical framework for PED-based continuous-flow systems, advancing operando characterization, expanding applications in pharmaceutical continuous manufacturing, and constructing PED-based biomimetic cell factories for carbon upgrading. PED-based fixed-bed systems thus emerge as a versatile platform for sustainable chemical manufacturing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.